Wikidata entity: Q415203
C₁₆H₂₁N₃ (P274)
Quantities
| P4250 | defined daily dose | 0.15 |
| P2067 | mass | 255.173548 |
| P233 | canonical SMILES | String | CN(C)CCN(CC1=CC=CC=C1)C2=CC=CC=N2 | ??? |
| P373 | Commons category | String | Tripelennamine | ??? |
| P366 | has use | ... | Q12140 (medication) | medication |
| P8224 | image of molecular model or crystal lattice model | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Tripelennaminefinal.png | ??? |
| P31 | instance of | ... | Q113145171 (type of chemical entity) | type of chemical entity |
| P2175 | medical condition treated | ... | Q187440 (urticaria) | urticaria |
| P129 | physically interacts with | ... | Q309513 (Histamine receptor H1) | Histamine receptor H1 |
| P5555 | schematic | CommonsMedia | http://commons.wikimedia.org/wiki/Special:FilePath/Tripelennamine%20synthesis.png | ??? |
| P279 | subclass of | ... | Q11173 (chemical compound) | chemical compound |
| P2868 | subject has role | ... | Q1328275 (H1 antagonist) | H1 antagonist |
| P2868 | subject has role | ... | Q50430264 (anti-allergic agents) | anti-allergic agents |
| P2275 | World Health Organisation international non-proprietary name | Monolingualtext | tripelennamine | ??? |
Why not click here or view trends?
log id: 2177540